weight-loss medicines should not be used during pregnancy, and good glucose control in pregnancy requires a different plan
STEP 5: the two-year study Duration matters for understanding the full timeline
Important safety considerations include monitoring for signs of pancreatitis (severe abdominal pain radiating to the back), gallbladder disease, and hypoglycemia, particularly in patients taking concurrent diabetes medications
Early Discoveries, With More to Come So far, GLP-1s, first approved 20 years ago for type 2 diabetes and later obesity, have shown potential in treating a surprisingly wide range of conditions, such as heart disease, Parkinsons, Alzheimers, sleep apnea, and liver disease
The FDA-approved GLP-1 medications come in injectable pens with precise dosing, whereas compounded GLP-1 drugs typically come in a vial with a syringe that can offer more flexibility for microdosing, but also opens up the chance for taking too much or too little medication